User: Guest  Login
Title:

The cost utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage lesions in Belgium.

Document type:
Journal Article; Research Support, Non-U.S. Gov't
Author(s):
Gerlier, L; Lamotte, M; Wille, M; Kreuz, PC; Vanlauwe, J; Dubois, D; Meurgey, FM
Abstract:
Knee cartilage lesions increase the risk of developing osteoarthritis (OA), and may eventually result in a total knee replacement (TKR). There is currently no consensus on the optimal treatment of cartilage lesions. ChondroCelect® (CC) is a cell-based therapy approved for use in autologous chondrocytes implantation (ACI) to treat symptomatic cartilage defects of the femoral condyle. Its capacity to safely restore good-quality cartilage was demonstrated in a randomized controlled trial (RCT) vers...     »
Journal title abbreviation:
Pharmacoeconomics
Year:
2010
Journal volume:
28
Journal issue:
12
Pages contribution:
1129-46
Language:
eng
Fulltext / DOI:
doi:10.2165/11584920-000000000-00000
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/21080737
Print-ISSN:
1170-7690
TUM Institution:
Klinik und Poliklinik für Orthopädie und Sportorthopädie
 BibTeX